The latest price and medical insurance coverage of Pazopanib in 2025

Pazopanib has been officially launched in China and has been included in the medical insurance system, providing patients with a more convenient drug purchase channel. Due to the inclusion in medical insurance, patients can obtain drugs through hospital pharmacies at a lower out-of-pocket rate if they meet the reimbursement conditions. Specific reimbursement ratios and policies may vary from region to region. It is recommended that patients consult the local hospital pharmacy or medical insurance department before purchasing drugs to ensure they understand the latest policies.

In the domestic market, the price of pazopanib original drug is about more than 1,000 yuan per box, and the common specifications are daily oral doses. After being included in medical insurance, the patient's actual out-of-pocket expenses will vary according to local medical insurance reimbursement policies and individual medical insurance types. Overall, medical insurance coverage has significantly reduced the financial burden on patients, allowing patients with more indications to successfully complete the treatment cycle.

In overseas markets, pazopanib has two options: original drug and generic drug. The price of original drugs is relatively high, usually several thousand or even tens of thousands of yuan per box, while the price of generic drugs is more affordable. Taking the Indian and Bangladeshi versions of generic drugs as an example, the price is only around a few hundred yuan, and the drug ingredients are basically the same as the original drugs, making them an economical choice. Overseas drug purchase channels are mainly through regular hospitals or overseas drug supply platforms, but attention must be paid to legal compliance and transportation safety.

When using pazopanib, patients should strictly follow the doctor's instructions and conduct regular monitoring according to the doctor's recommendations, including liver function, blood pressure and hematological indicators. If patients can purchase drugs through medical insurance in China, it is recommended to give priority to domestic formal channels to ensure drug quality and safety. For patients who want to purchase generic drugs through overseas channels, they should fully understand the source, price and legality of the drugs, and choose the most appropriate way to purchase drugs based on their own economic situation and treatment needs.

Reference link:https://www.drugs.com